RNID’s Hearing Therapeutics Initiative is here to support innovators developing treatments for hearing loss and tinnitus. Join the network to help accelerate progress in this research.
What we offer
Scientific, clinical and market insight expertise
We can connect you to world-leading experts to access their advice, tailored to your specific innovation needs.
Strategic collaborations
We build relationships between biotech, academia, and investors creating new opportunities and partnerships.
Funding and research commercialisation support
From grant guidance to investor introductions, we help you secure the investment needed to advance your programmes.
Advocacy and visibility
We can showcase your work through events and across our communication channels – raising awareness and driving interest in your innovation.
Community
We help you stay connected – offering ongoing support and building a community that together can help shape the future of hearing therapeutics.
How the HTI works
The Hearing Therapeutics Initiative brings together:
- a consortium of partner organisations with unique knowledge, expertise and infrastructure in hearing research, drug discovery and development
- a global Network of innovators from academia and industry looking for tailored support to help them develop new hearing therapeutics
- innovators with the infrastructure and expertise they need, at every step of the translational pathway.
By joining the network you’ll receive tailored support for your translational research, bi-monthly newsletters with updates on the hearing therapeutics sector, consulting and collaboration opportunities, and invitations to HTI activities and events.
